{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:03:32Z","timestamp":1782965012690,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41409-021-01497-2","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T09:02:49Z","timestamp":1634979769000},"page":"167-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["HEV infection in stem cell transplant recipients\u2014retrospective study of EBMT Infectious Diseases Working Party"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5535-4602","authenticated-orcid":false,"given":"Malgorzata","family":"Mikulska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Penack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotus","family":"Wendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Knelange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Blijlevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Passweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kroger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7025-1735","authenticated-orcid":false,"given":"Christian","family":"Koenecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-3080","authenticated-orcid":false,"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8533-2562","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Pi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Labussiere-Wallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Ghesquieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7465-6203","authenticated-orcid":false,"given":"Antonia","family":"Sampol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-7274","authenticated-orcid":false,"given":"Diana","family":"Averbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-5779","authenticated-orcid":false,"given":"Rafael","family":"de la Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3158-119X","authenticated-orcid":false,"given":"Jan","family":"Styczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"1497_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"JH Hoofnagle","year":"2012","unstructured":"Hoofnagle JH, Nelson KE, Purcell RH. Hepatitis E. N. Engl J Med. 2012;367:1237\u201344. https:\/\/doi.org\/10.1056\/NEJMra1204512.","journal-title":"N. Engl J Med"},{"key":"1497_CR2","doi-asserted-by":"publisher","unstructured":"Kamar N, Pischke S. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment. Cold Spring Harbor Perspect Med. 2019;9. https:\/\/doi.org\/10.1101\/cshperspect.a031872.","DOI":"10.1101\/cshperspect.a031872"},{"key":"1497_CR3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa0706992","volume":"358","author":"N Kamar","year":"2008","unstructured":"Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl J Med. 2008;358:811\u20137. https:\/\/doi.org\/10.1056\/NEJMoa0706992.","journal-title":"N. Engl J Med"},{"key":"1497_CR4","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1182\/blood-2013-03-492363","volume":"122","author":"J Versluis","year":"2013","unstructured":"Versluis J, Pas SD, Agteresch HJ, de Man RA, Maaskant J, Schipper ME, et al. Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:1079\u201386. https:\/\/doi.org\/10.1182\/blood-2013-03-492363.","journal-title":"Blood"},{"key":"1497_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-94-024-0942-0_6","volume":"948","author":"Y Geng","year":"2016","unstructured":"Geng Y, Wang Y. Transmission of Hepatitis E Virus. Adv Exp Med Biol. 2016;948:89\u2013112. https:\/\/doi.org\/10.1007\/978-94-024-0942-0_6.","journal-title":"Adv Exp Med Biol"},{"key":"1497_CR6","doi-asserted-by":"publisher","unstructured":"Harvala H, Hewitt PE, Reynolds C, Pearson C, Haywood B, Tettmar KI et al. Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2019;24. https:\/\/doi.org\/10.2807\/1560-7917.es.2019.24.10.1800386.","DOI":"10.2807\/1560-7917.es.2019.24.10.1800386"},{"key":"1497_CR7","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/s0140-6736(14)61034-5","volume":"384","author":"PE Hewitt","year":"2014","unstructured":"Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet (Lond, Engl). 2014;384:1766\u201373. https:\/\/doi.org\/10.1016\/s0140-6736(14)61034-5.","journal-title":"Lancet (Lond, Engl)"},{"key":"1497_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/MEG.0b013e3282f5195a","volume":"20","author":"HR Dalton","year":"2008","unstructured":"Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2008;20:784\u201390. https:\/\/doi.org\/10.1097\/MEG.0b013e3282f5195a.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1497_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/jmv.20206","volume":"74","author":"JM Mansuy","year":"2004","unstructured":"Mansuy JM, Peron JM, Abravanel F, Poirson H, Dubois M, Miedouge M, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol. 2004;74:419\u201324. https:\/\/doi.org\/10.1002\/jmv.20206.","journal-title":"J Med Virol"},{"key":"1497_CR10","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1086\/593211","volume":"198","author":"O Wichmann","year":"2008","unstructured":"Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis. 2008;198:1732\u201341. https:\/\/doi.org\/10.1086\/593211.","journal-title":"J Infect Dis"},{"key":"1497_CR11","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","volume":"8","author":"N Kamar","year":"2008","unstructured":"Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg. 2008;8:1744\u20138. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02286.x.","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"1497_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/qco.0000000000000076","volume":"27","author":"AA van der Eijk","year":"2014","unstructured":"van der Eijk AA, Pas SD, Cornelissen JJ, de Man RA. Hepatitis E virus infection in hematopoietic stem cell transplant recipients. Curr Opin Infect Dis. 2014;27:309\u201315. https:\/\/doi.org\/10.1097\/qco.0000000000000076.","journal-title":"Curr Opin Infect Dis"},{"key":"1497_CR13","doi-asserted-by":"publisher","unstructured":"von Felden J, Alric L, Pischke S, Aitken C, Schlabe S, Spengler U, et al. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study. J Hepatol. 2019. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.022.","DOI":"10.1016\/j.jhep.2019.04.022"},{"key":"1497_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jceh.2013.05.003","volume":"3","author":"N Kamar","year":"2013","unstructured":"Kamar N, Izopet J, Dalton HR. Chronic hepatitis e virus infection and treatment. J Clin Exp Hepatol. 2013;3:134\u201340. https:\/\/doi.org\/10.1016\/j.jceh.2013.05.003.","journal-title":"J Clin Exp Hepatol"},{"key":"1497_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/s1473-3099(16)00118-3","volume":"16","author":"V Mallet","year":"2016","unstructured":"Mallet V, van Bommel F, Doerig C, Pischke S, Hermine O, Locasciulli A, et al. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis. 2016;16:606\u201317. https:\/\/doi.org\/10.1016\/s1473-3099(16)00118-3.","journal-title":"Lancet Infect Dis"},{"key":"1497_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/hep.24738","volume":"55","author":"PV Suneetha","year":"2012","unstructured":"Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology. 2012;55:695\u2013708.","journal-title":"Hepatology"},{"key":"1497_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/cmr.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116\u201338. https:\/\/doi.org\/10.1128\/cmr.00057-13.","journal-title":"Clin Microbiol Rev"},{"key":"1497_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","volume":"140","author":"N Kamar","year":"2011","unstructured":"Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2011.02.050.","journal-title":"Gastroenterology"},{"key":"1497_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jcv.2012.02.015","volume":"54","author":"F Abravanel","year":"2012","unstructured":"Abravanel F, Mansuy JM, Huynh A, Kamar N, Alric L, Peron JM, et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol. 2012;54:152\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2012.02.015.","journal-title":"J Clin Virol"},{"key":"1497_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1399-3062.2011.00702.x","volume":"14","author":"C Koenecke","year":"2012","unstructured":"Koenecke C, Pischke S, Heim A, Raggub L, Bremer B, Raupach R, et al. Chronic hepatitis E in hematopoietic stem cell transplant patients in a low-endemic country? Transpl Infect Dis: Off J Transplant Soc. 2012;14:103\u20136. https:\/\/doi.org\/10.1111\/j.1399-3062.2011.00702.x.","journal-title":"Transpl Infect Dis: Off J Transplant Soc"},{"key":"1497_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2018.07.011","volume":"107","author":"I Reekie","year":"2018","unstructured":"Reekie I, Irish D, Ijaz S, Fox T, Bharucha T, Griffiths P, et al. Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period. J Clin Virol. 2018;107:1\u20135. https:\/\/doi.org\/10.1016\/j.jcv.2018.07.011.","journal-title":"J Clin Virol"},{"key":"1497_CR22","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/bjh.15672","volume":"184","author":"FF Tang","year":"2019","unstructured":"Tang FF, Mo XD, Wang Y, Yan CH, Chen YH, Chen H, et al. Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical course. Br J Haematol. 2019;184:788\u201396. https:\/\/doi.org\/10.1111\/bjh.15672.","journal-title":"Br J Haematol"},{"key":"1497_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/bmt.2016.327","volume":"52","author":"SB Willemse","year":"2017","unstructured":"Willemse SB, Bezuur DL, Blom P, Kneppers E, Verheij J, Zaaijer HL, et al. Hepatitis E virus infection and hepatic GvHD in allogeneic hematopoietic stem cell transplantation recipients. Bone marrow Transplant. 2017;52:622\u20134. https:\/\/doi.org\/10.1038\/bmt.2016.327.","journal-title":"Bone marrow Transplant"},{"key":"1497_CR24","doi-asserted-by":"publisher","unstructured":"Xhaard A, Roque-Afonso AM, Mallet V, Ribaud P, Nguyen-Quoc S, Rohrlich PS et al. Hepatitis E and Allogeneic Hematopoietic Stem Cell Transplantation: A French Nationwide SFGM-TC Retrospective Study. Viruses. 2019;11. https:\/\/doi.org\/10.3390\/v11070622.","DOI":"10.3390\/v11070622"},{"key":"1497_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcv.2019.08.002","volume":"119","author":"S Cruz","year":"2019","unstructured":"Cruz S, Campos C, Timoteo M, Tavares A, Jose Nascimento MS, Medeiros R, et al. Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review. J Clin Virol. 2019;119:31\u201336. https:\/\/doi.org\/10.1016\/j.jcv.2019.08.002.","journal-title":"J Clin Virol"},{"key":"1497_CR26","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.bbmt.2020.03.012","volume":"26","author":"E Furfaro","year":"2020","unstructured":"Furfaro E, Nicolini L, Della Vecchia A, Di Grazia C, Raiola AM, Varaldo R, et al. Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection. Biol Blood Marrow Transpl. 2020;26:1355\u201362. https:\/\/doi.org\/10.1016\/j.bbmt.2020.03.012.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1497_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/s41409-020-0823-7","volume":"55","author":"L Swartling","year":"2020","unstructured":"Swartling L, Nord\u00e9n R, Samuelsson E, Boriskina K, Valentini D, Westin J, et al. Hepatitis E virus is an infrequent but potentially serious infection in allogeneic hematopoietic stem cell transplant recipients. Bone marrow Transplant. 2020;55:1255\u201363. https:\/\/doi.org\/10.1038\/s41409-020-0823-7.","journal-title":"Bone marrow Transplant"},{"key":"1497_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/liv.14695","volume":"41","author":"G Buescher","year":"2021","unstructured":"Buescher G, Ozga AK, Lorenz E, Pischke S, May J, Addo MM, et al. Hepatitis E seroprevalence and viremia rate in immunocompromised patients: a systematic review and meta-analysis. Liver Int: Off J Int Assoc Study Liver. 2021;41:449\u201355. https:\/\/doi.org\/10.1111\/liv.14695.","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"key":"1497_CR29","doi-asserted-by":"publisher","unstructured":"EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.005.","DOI":"10.1016\/j.jhep.2018.03.005"},{"key":"1497_CR30","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3201\/eid2108.150199","volume":"21","author":"S Tavitian","year":"2015","unstructured":"Tavitian S, Peron JM, Huguet F, Kamar N, Abravanel F, Beyne-Rauzy O, et al. Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies. Emerg Infect Dis. 2015;21:1466\u20139. https:\/\/doi.org\/10.3201\/eid2108.150199.","journal-title":"Emerg Infect Dis"},{"key":"1497_CR31","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/tp.0000000000002097","volume":"102","author":"MJ Ankcorn","year":"2018","unstructured":"Ankcorn MJ, Ijaz S, Poh J, Elsharkawy AM, Smit E, Cramb R, et al. Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients. Transplantation. 2018;102:1139\u201347. https:\/\/doi.org\/10.1097\/tp.0000000000002097.","journal-title":"Transplantation"},{"key":"1497_CR32","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/bmt.2012.25","volume":"47","author":"P Barba","year":"2012","unstructured":"Barba P, Martino R, Perez-Sim\u00f3n JA, Fern\u00e1ndez-Avil\u00e9s F, Pi\u00f1ana JL, Valc\u00e1rcel D, et al. Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning. Bone marrow Transplant. 2012;47:1343\u20139. https:\/\/doi.org\/10.1038\/bmt.2012.25.","journal-title":"Bone marrow Transplant"},{"key":"1497_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1055\/s-0033-1338115","volume":"33","author":"N Kamar","year":"2013","unstructured":"Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. Semin liver Dis. 2013;33:62\u201370. https:\/\/doi.org\/10.1055\/s-0033-1338115.","journal-title":"Semin liver Dis"},{"key":"1497_CR34","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1111\/ajt.13428","volume":"15","author":"S Meisner","year":"2015","unstructured":"Meisner S, Polywka S, Memmler M, Nashan B, Lohse AW, Sterneck M, et al. Definition of chronic hepatitis E after liver transplant conforms to convention. Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg. 2015;15:3011\u20132. https:\/\/doi.org\/10.1111\/ajt.13428.","journal-title":"Am J Transplant: Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"1497_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000499121","volume":"46","author":"F Boland","year":"2019","unstructured":"Boland F, Martinez A, Pomeroy L, O\u2019Flaherty N. Blood Donor Screening for Hepatitis E Virus in the European Union. Transfus Med hemotherapy: offizielles Organ der Dtsch Ges fur Transfusionsmedizin und Immunhamatologie. 2019;46:95\u2013103. https:\/\/doi.org\/10.1159\/000499121.","journal-title":"Transfus Med hemotherapy: offizielles Organ der Dtsch Ges fur Transfusionsmedizin und Immunhamatologie"},{"key":"1497_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/trf.13978","volume":"57","author":"AS de Vos","year":"2017","unstructured":"de Vos AS, Janssen MP, Zaaijer HL, Hogema BM. Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands. Transfusion. 2017;57:258\u201366. https:\/\/doi.org\/10.1111\/trf.13978.","journal-title":"Transfusion"},{"key":"1497_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jhep.2018.02.031","volume":"69","author":"D Westholter","year":"2018","unstructured":"Westholter D, Hiller J, Denzer U, Polywka S, Ayuk F, Rybczynski M, et al. HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. J Hepatol. 2018;69:36\u201342. https:\/\/doi.org\/10.1016\/j.jhep.2018.02.031.","journal-title":"J Hepatol"},{"key":"1497_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijid.2019.11.014","volume":"91","author":"LH Harritsh\u00f8j","year":"2020","unstructured":"Harritsh\u00f8j LH, Hother CE, Sengel\u00f8v H, Daugaard G, S\u00f8rensen SS, Jacobsen S, et al. Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients. Int J Infect Dis. 2020;91:188\u201395. https:\/\/doi.org\/10.1016\/j.ijid.2019.11.014.","journal-title":"Int J Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01497-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01497-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T19:04:08Z","timestamp":1644260648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-021-01497-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1497"],"URL":"https:\/\/doi.org\/10.1038\/s41409-021-01497-2","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"OP has no conflict of interests directly related to this manuscript. He has received honoraria or travel support from Astellas, Gilead, Jazz, MSD, Neovii Biotech, Novartis, Pfizer and Therakos. He has received research support from Gilead, Incyte, Jazz, Neovii Biotech and Takeda. He is member of advisory boards to Jazz, Gilead, MSD, Omeros, Priothera, Shionogi and SOBI. All other authors: nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}